{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:44:48Z","timestamp":1759963488137},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s11926-008-0032-7","type":"journal-article","created":{"date-parts":[[2008,10,23]],"date-time":"2008-10-23T19:02:25Z","timestamp":1224788545000},"page":"189-194","source":"Crossref","is-referenced-by-count":7,"title":["Cellular therapy of systemic sclerosis"],"prefix":"10.1007","volume":"10","author":[{"given":"Jacob M.","family":"van Laar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Tyndall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,24]]},"reference":[{"key":"32_CR1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-3083.1994.tb03383.x","volume":"39","author":"E.D. Thomas","year":"1994","unstructured":"Thomas ED: The Nobel Lectures in Immunology. The Nobel Prize for Physiology or Medicine, 1990. Bone marrow transplantation-past, present and future. Scand J Immunol 1994, 39:339\u2013345.","journal-title":"Scand J Immunol"},{"key":"32_CR2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.beha.2004.04.004","volume":"17","author":"A.M. Marmont","year":"2004","unstructured":"Marmont AM: Stem cell transplantation for autoimmune disorders. Coincidental autoimmune disease in patients transplanted for conventional indications. Best Pract Res Clin Haematol 2004, 17:223\u2013232.","journal-title":"Best Pract Res Clin Haematol"},{"key":"32_CR3","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20041679","volume":"201","author":"P.A. Muraro","year":"2005","unstructured":"Muraro PA, Douek DC, Packer A, et al.: Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 2005, 201:805\u2013816.","journal-title":"J Exp Med"},{"key":"32_CR4","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/art.21036","volume":"52","author":"D. Farge","year":"2005","unstructured":"Farge D, Henegar C, Carmagnat M, et al.: Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis. Arthritis Rheum 2005, 52:1555\u20131563.","journal-title":"Arthritis Rheum"},{"key":"32_CR5","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","volume":"363","author":"K. Blanc Le","year":"2004","unstructured":"Le Blanc K, Rasmusson I, Sundberg B, et al.: Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004, 363:1439\u20131441.","journal-title":"Lancet"},{"key":"32_CR6","first-page":"473","volume":"7","author":"P. Taupin","year":"2006","unstructured":"Taupin P: OTI-010 Osiris Therapeutics\/JCR Pharmaceuticals. Curr Opin Investig Drugs 2006, 7:473\u2013481.","journal-title":"Curr Opin Investig Drugs"},{"key":"32_CR7","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/rheumatology\/kel158","volume":"45","author":"J.M. Laar van","year":"2006","unstructured":"van Laar JM, Tyndall A: Adult stem cells in the treatment of autoimmune diseases. Rheumatology (Oxford) 2006, 45:1187\u20131193.","journal-title":"Rheumatology (Oxford)"},{"key":"32_CR8","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/sj.bmt.1704892","volume":"35","author":"A. Gratwohl","year":"2005","unstructured":"Gratwohl A, Passweg J, Bocelli-Tyndall C, et al.: Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 2005, 35:869\u2013879.","journal-title":"Bone Marrow Transplant"},{"key":"32_CR9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/ard.60.6.577","volume":"60","author":"M. Binks","year":"2001","unstructured":"Binks M, Passweg JR, Furst D, et al.: Phase I\/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. Ann Rheum Dis 2001, 60:577\u2013584.","journal-title":"Ann Rheum Dis"},{"key":"32_CR10","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/ard.2003.011205","volume":"63","author":"D. Farge","year":"2004","unstructured":"Farge D, Passweg J, van Laar JM, et al.: Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT\/EULAR Registry. Ann Rheum Dis 2004, 63:974\u2013981.","journal-title":"Ann Rheum Dis"},{"key":"32_CR11","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood-2007-02-072389","volume":"110","author":"R.A. Nash","year":"2007","unstructured":"Nash RA, McSweeney PA, Crofford LJ, et al.: High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study. Blood 2007, 110:1388\u20131396.","journal-title":"Blood"},{"key":"32_CR12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/ard.2007.071464","volume":"67","author":"M.C. Vonk","year":"2008","unstructured":"Vonk MC, Marjanovic Z, van den Hoogen FH, et al.: Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis. Ann Rheum Dis 2008, 67:98\u2013104.","journal-title":"Ann Rheum Dis"},{"key":"32_CR13","doi-asserted-by":"crossref","first-page":"e1452","DOI":"10.1371\/journal.pone.0001452","volume":"3","author":"J.N. Fleming","year":"2008","unstructured":"Fleming JN, Nash RA, McLeod DO, et al.: Capillary regeneration in scleroderma: stem cell therapy reverses phenotype? PLoS ONE 2008, 3:e1452.","journal-title":"PLoS ONE"},{"key":"32_CR14","doi-asserted-by":"crossref","unstructured":"Aschwanden M, Daikeler T, Jaeger K, et al.: Rapid improvement of nailfold capillaroscopy after intense immunosuppression for systemic sclerosis and mixed connective tissue damage. Ann Rheum Dis 2008 (in press).","DOI":"10.1136\/ard.2007.082008"},{"key":"32_CR15","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1136\/ard.2005.043240","volume":"64","author":"J.M. Laar van","year":"2005","unstructured":"van Laar JM, Farge D, Tyndall A: Autologous Stem Cell Transplantation International Scleroderma (ASTIS) trial: hope on the horizon for patients with severe systemic sclerosis. Ann Rheum Dis 2005, 64:1515.","journal-title":"Ann Rheum Dis"},{"key":"32_CR16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00007890-196803000-00009","volume":"6","author":"A.J. Friedenstein","year":"1968","unstructured":"Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP: Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968, 6:230\u2013247.","journal-title":"Transplantation"},{"key":"32_CR17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/8756-3282(92)90364-3","volume":"13","author":"S.E. Haynesworth","year":"1992","unstructured":"Haynesworth SE, Goshima J, Goldberg VM, Caplan AI: Characterization of cells with osteogenic potential from human marrow. Bone 1992, 13:81\u201388.","journal-title":"Bone"},{"key":"32_CR18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1126\/science.276.5309.71","volume":"276","author":"D.J. Prockop","year":"1997","unstructured":"Prockop DJ: Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276:71\u201374.","journal-title":"Science"},{"key":"32_CR19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"M.F. Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC, et al.: Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143\u2013147.","journal-title":"Science"},{"key":"32_CR20","first-page":"83","volume":"2","author":"A.J. Friedenstein","year":"1974","unstructured":"Friedenstein AJ, Deriglasova UF, Kulagina NN, et al.: Precursors for fi broblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 1974, 2:83\u201392.","journal-title":"Exp Hematol"},{"key":"32_CR21","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/0014-4827(91)90401-F","volume":"195","author":"H. Nakahara","year":"1991","unstructured":"Nakahara H, Dennis JE, Bruder SP, et al.: In vitro differentiation of bone and hypertrophic cartilage from periosteal-derived cells. Exp Cell Res 1991, 195:492\u2013503.","journal-title":"Exp Cell Res"},{"key":"32_CR22","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1073\/pnas.81.11.3419","volume":"81","author":"T.K. Sampath","year":"1984","unstructured":"Sampath TK, Nathanson MA, Reddi AH: In vitro transformation of mesenchymal cells derived from embryonic muscle into cartilage in response to extracellular matrix components of bone. Proc Natl Acad Sci U S A 1984, 81:3419\u20133423.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"32_CR23","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1002\/art.10696","volume":"46","author":"E.A. Jones","year":"2002","unstructured":"Jones EA, Kinsey SE, English A, et al.: Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 2002, 46:3349\u20133360.","journal-title":"Arthritis Rheum"},{"key":"32_CR24","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2174\/157488807782793763","volume":"2","author":"K. Bieback","year":"2007","unstructured":"Bieback K, Kluter H: Mesenchymal stromal cells from umbilical cord blood. Curr Stem Cell Res Ther 2007, 2:310\u2013323.","journal-title":"Curr Stem Cell Res Ther"},{"key":"32_CR25","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/term.40","volume":"1","author":"M. Soncini","year":"2007","unstructured":"Soncini M, Vertua E, Gibelli L, et al.: Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med 2007, 1:296\u2013305.","journal-title":"J Tissue Eng Regen Med"},{"key":"32_CR26","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/14653240500319234","volume":"7","author":"E. Horwitz","year":"2005","unstructured":"Horwitz E, Le Blanc K, Dominici M, et al.: Clarifi cation of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005, 7:393\u2013395.","journal-title":"Cytotherapy"},{"key":"32_CR27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/art.22111","volume":"55","author":"A. Tyndall","year":"2006","unstructured":"Tyndall A, LeBlanc K: Stem cells and rheumatology: update on adult stem cell therapy in autoimmune diseases. Arthritis Rheum 2006, 55:521\u2013525.","journal-title":"Arthritis Rheum"},{"key":"32_CR28","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1182\/blood-2005-11-011650","volume":"108","author":"A.J. Nauta","year":"2006","unstructured":"Nauta AJ, Westerhuis G, Kruisselbrink AB, et al.: Donorderived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a non-myeloablative setting. Blood 2006, 108:2114\u20132120.","journal-title":"Blood"},{"key":"32_CR29","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1182\/blood-2005-03-1004","volume":"106","author":"N. Eliopoulos","year":"2005","unstructured":"Eliopoulos N, Stagg J, Lejeune L, et al.: Allogeneic marrow stromal cells are immune rejected by MHC class I-and class II-mismatched recipient mice. Blood 2005, 106:4057\u20134065.","journal-title":"Blood"},{"key":"32_CR30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.TP.0000045055.63901.A9","volume":"75","author":"W.T. Tse","year":"2003","unstructured":"Tse WT, Pendleton JD, Beyer WM, et al.: Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003, 75:389\u2013397.","journal-title":"Transplantation"},{"key":"32_CR31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-3083.2003.01176.x","volume":"57","author":"K. Blanc Le","year":"2003","unstructured":"Le Blanc K, Tammik L, Sundberg B, et al.: Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003, 57:11\u201320.","journal-title":"Scand J Immunol"},{"key":"32_CR32","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","volume":"99","author":"M. Nicola Di","year":"2002","unstructured":"Di Nicola M, Carlo-Stella C, Magni M, et al.: Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecifi c mitogenic stimuli. Blood 2002, 99:3838\u20133843.","journal-title":"Blood"},{"key":"32_CR33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11373-004-8183-7","volume":"12","author":"E. Klyushnenkova","year":"2005","unstructured":"Klyushnenkova E, Mosca JD, Zernetkina V, et al.: T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci 2005, 12:47\u201357.","journal-title":"J Biomed Sci"},{"key":"32_CR34","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1182\/blood-2002-07-2104","volume":"101","author":"M. Krampera","year":"2003","unstructured":"Krampera M, Glennie S, Dyson J, et al.: Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specifi c T cells to their cognate peptide. Blood 2003, 101:3722\u20133729.","journal-title":"Blood"},{"key":"32_CR35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0301-472X(01)00769-X","volume":"30","author":"A. Bartholomew","year":"2002","unstructured":"Bartholomew A, Sturgeon C, Siatskas M, et al.: Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002, 30:42\u201348.","journal-title":"Exp Hematol"},{"key":"32_CR36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","volume":"107","author":"A. Corcione","year":"2006","unstructured":"Corcione A, Benvenuto F, Ferretti E, et al.: Human mesenchymal stem cells modulate B cell functions. Blood 2006, 107:367\u2013372.","journal-title":"Blood"},{"key":"32_CR37","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1182\/blood-2004-09-3696","volume":"105","author":"S. Glennie","year":"2005","unstructured":"Glennie S, Soeiro I, Dyson PJ, et al.: Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005, 105:2821\u20132827.","journal-title":"Blood"},{"key":"32_CR38","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/01.TP.0000082540.43730.80","volume":"76","author":"I. Rasmusson","year":"2003","unstructured":"Rasmusson I, Ringden O, Sundberg B, Le Blanc K: Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 2003, 76:1208\u20131213.","journal-title":"Transplantation"},{"key":"32_CR39","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","volume":"105","author":"S. Aggarwal","year":"2005","unstructured":"Aggarwal S, Pittenger MF: Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815\u20131822.","journal-title":"Blood"},{"key":"32_CR40","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","volume":"103","author":"R. Meisel","year":"2004","unstructured":"Meisel R, Zibert A, Laryea M, et al.: Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004, 103:4619\u20134621.","journal-title":"Blood"},{"key":"32_CR41","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1182\/blood-2006-02-002246","volume":"109","author":"K. Sato","year":"2006","unstructured":"Sato K, Ozaki K, Oh I, et al.: Nitric oxide plays a critical role in suppression of T cell proliferation by mesenchymal stem cells. Blood 2006, 109:228\u2013234.","journal-title":"Blood"},{"key":"32_CR42","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.tp.0000267918.07906.08","volume":"84","author":"A. Nasef","year":"2007","unstructured":"Nasef A, Mathieu N, Chapel A, et al.: Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G. Transplantation 2007, 84:231\u2013237.","journal-title":"Transplantation"},{"key":"32_CR43","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.1073\/pnas.1432929100","volume":"100","author":"L.A. Ortiz","year":"2003","unstructured":"Ortiz LA, Gambelli F, McBride C, et al.: Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fi brotic effects. Proc Natl Acad Sci U S A 2003, 100:8407\u20138411.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"32_CR44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/01.TP.0000128326.95294.14","volume":"78","author":"B. Fang","year":"2004","unstructured":"Fang B, Shi M, Liao L, et al.: Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachlorideinduced liver fi brosis in mice. Transplantation 2004, 78:83\u201388.","journal-title":"Transplantation"},{"key":"32_CR45","doi-asserted-by":"crossref","first-page":"F31","DOI":"10.1152\/ajprenal.00007.2005","volume":"289","author":"F. Togel","year":"2005","unstructured":"Togel F, Hu Z, Weiss K, et al.: Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 2005, 289:F31\u2013F42.","journal-title":"Am J Physiol Renal Physiol"},{"key":"32_CR46","doi-asserted-by":"crossref","first-page":"F1626","DOI":"10.1152\/ajprenal.00339.2006","volume":"292","author":"F. Togel","year":"2007","unstructured":"Togel F, Weiss K, Yang Y, et al.: Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 2007, 292:F1626\u2013F1635.","journal-title":"Am J Physiol Renal Physiol"},{"key":"32_CR47","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/rheumatology\/kel267","volume":"46","author":"C. Bocelli-Tyndall","year":"2007","unstructured":"Bocelli-Tyndall C, Bracci L, Spagnoli G, et al.: Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous-and allogeneic-stimulated lymphocytes in vitro. Rheumatology (Oxford) 2007, 46:403\u2013408.","journal-title":"Rheumatology (Oxford)"},{"key":"32_CR48","doi-asserted-by":"crossref","unstructured":"Larghero J, Farge D, Braccini A, et al.: Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from systemic sclerosis patients. Ann Rheum Dis 2007 (Epub ahead of print).","DOI":"10.1136\/ard.2007.071233"},{"key":"32_CR49","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/art.22698","volume":"56","author":"P. Cipriani","year":"2007","unstructured":"Cipriani P, Guiducci S, Miniati I, et al.: Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis. Arthritis Rheum 2007, 56:1994\u20132004.","journal-title":"Arthritis Rheum"},{"key":"32_CR50","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1582-4934.2007.00120.x","volume":"11","author":"S.G. Ball","year":"2007","unstructured":"Ball SG, Shuttleworth CA, Kielty CM: Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors. J Cell Mol Med 2007, 11:1012\u20131030.","journal-title":"J Cell Mol Med"},{"key":"32_CR51","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1182\/blood-2003-04-1193","volume":"102","author":"F. Djouad","year":"2003","unstructured":"Djouad F, Plence P, Bony C, et al.: Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003, 102:3837\u20133844.","journal-title":"Blood"},{"key":"32_CR52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.expneurol.2005.03.018","volume":"195","author":"J. Zhang","year":"2005","unstructured":"Zhang J, Li Y, Chen J, et al.: Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp Neurol 2005, 195:16\u201326.","journal-title":"Exp Neurol"},{"key":"32_CR53","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2005-04-1496","volume":"106","author":"E. Zappia","year":"2005","unstructured":"Zappia E, Casazza S, Pedemonte E, et al.: Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005, 106:1755\u20131761.","journal-title":"Blood"},{"key":"32_CR54","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/art.21012","volume":"52","author":"F. Djouad","year":"2005","unstructured":"Djouad F, Fritz V, Apparailly F, et al.: Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum 2005, 52:1595\u20131603.","journal-title":"Arthritis Rheum"},{"key":"32_CR55","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/art.22511","volume":"56","author":"A. Augello","year":"2007","unstructured":"Augello A, Tasso R, Negrini SM, et al.: Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum 2007, 56:1175\u20131186.","journal-title":"Arthritis Rheum"},{"key":"32_CR56","first-page":"557","volume":"16","author":"H.M. Lazarus","year":"1995","unstructured":"Lazarus HM, Haynesworth SE, Gerson SL, et al.: Ex vivo expansion and subsequent infusion of human bone marrowderived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 1995, 16:557\u2013564.","journal-title":"Bone Marrow Transplant"},{"key":"32_CR57","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2005.02.001","volume":"11","author":"H.M. Lazarus","year":"2005","unstructured":"Lazarus HM, Koc ON, Devine SM, et al.: Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005, 11:389\u2013398.","journal-title":"Biol Blood Marrow Transplant"},{"key":"32_CR58","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.bmt.1703650","volume":"30","author":"O.N. Koc","year":"2002","unstructured":"Koc ON, Day J, Nieder M, et al.: Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 2002, 30:215\u2013222.","journal-title":"Bone Marrow Transplant"},{"key":"32_CR59","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1200\/JCO.2000.18.2.307","volume":"18","author":"O.N. Koc","year":"2000","unstructured":"Koc ON, Gerson SL, Cooper BW, et al.: Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000, 18:307\u2013316.","journal-title":"J Clin Oncol"},{"key":"32_CR60","doi-asserted-by":"crossref","first-page":"8932","DOI":"10.1073\/pnas.132252399","volume":"99","author":"E.M. Horwitz","year":"2002","unstructured":"Horwitz EM, Gordon PL, Koo WK, et al.: Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A 2002, 99:8932\u20138937.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"32_CR61","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/sj.leu.2402786","volume":"17","author":"L. Fouillard","year":"2003","unstructured":"Fouillard L, Bensidhoum M, Bories D, et al.: Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma. Leukemia 2003, 17:474\u2013476.","journal-title":"Leukemia"},{"key":"32_CR62","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.bmt.1705920","volume":"41","author":"K. Blanc Le","year":"2008","unstructured":"Le Blanc K, Fibbe W: A new cell therapy registry coordinated by the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 2008, 41:319.","journal-title":"Bone Marrow Transplant"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-008-0032-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-008-0032-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-008-0032-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:49:49Z","timestamp":1559436589000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-008-0032-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["32"],"URL":"https:\/\/doi.org\/10.1007\/s11926-008-0032-7","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}